<DOC>
	<DOCNO>NCT00876226</DOCNO>
	<brief_summary>This prospective study determine pharmacokinetic parameter citalopram 12 adult patient short bowel syndrome . While data prevalence depression patient short bowel syndrome sparse , investigator ' experience patient high incidence depression benefit psychopharmacological intervention .</brief_summary>
	<brief_title>Pharmacokinetics Citalopram Patients With Short Bowel Syndrome</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Short Bowel Syndrome</mesh_term>
	<mesh_term>Citalopram</mesh_term>
	<mesh_term>Dexetimide</mesh_term>
	<criteria>Subjects must age 1965 year . Subjects must less 200cm functional small intestine . Subjects must least one month post bowel resection . Subjects less 19 year 65 year age . Pregnant breastfeed woman . Known hypersensitivity citalopram SSRIs . Diagnosis depression use MINI ( Mini International Neuropsychiatric Interview ) . Ongoing antidepressant therapy . Evidence cirrhosis ( ChildPugh stag B C ) evidence significant liver impairment define liver enzymes elevation great 2.5 time upper limit normal . Suicidal ideation . Bipolar disorder . Mania . Known history seizure . Evidence hyponatremia .</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2014</verification_date>
	<keyword>Citalopram</keyword>
	<keyword>Pharmacokinetics</keyword>
	<keyword>Short Bowel Syndrome</keyword>
</DOC>